Nicolas M. Furiak

Medication adherence levels and differential use of mental-health services in the treatment of schizophrenia

Haya Ascher‐Svanum, Baojin Zhu, Douglas E. Faries et al. · BMC Research Notes · 2009 · 59 citations · Full text

Pharmacy, Pharmacotherapy, Psychiatry +17

Cost-effectiveness model comparing olanzapine and other oral atypical antipsychotics in the treatment of schizophrenia in the United States

Nicolas M. Furiak, Haya Ascher‐Svanum, Robert W. Klein et al. · Cost Effectiveness and Resource Allocation · 2009 · 44 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Cost-effectiveness of several atypical antipsychotics in orally disintegrating tablets compared with standard oral tablets in the treatment of schizophrenia in the United States

Haya Ascher‐Svanum, Nicolas M. Furiak, Anthony H. Lawson et al. · Journal of Medical Economics · 2012 · 36 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Modeling screening, prevention, and delaying of Alzheimer's disease: an early-stage decision analytic model

Nicolas M. Furiak, Robert W. Klein, Kristin Kahle‐Wrobleski et al. · BMC Medical Informatics and Decision Making · 2010 · 14 citations · Full text

Medicine, Geriatric Medicine, Preventive Medicine +17

Development, Validation, and Application of a Microsimulation Model to Predict Stroke and Mortality in Medically Managed Asymptomatic Patients with Significant Carotid Artery Stenosis

Harry J. Smolen, David J. Cohen, Gregory P. Samsa et al. · Value in Health · 2007 · 13 citations · Full text

Medicine, Neurology, Surgery +14